13 gen 2021
Pruritus Intensity Scales across Europe: A Prospective Validation Study
Chronic pruritus (CP) is a subjective symptom and it is necessary to assess its intensity with validated patient-reported outcome tools in order to allow determination of the treatment course
13 gen 2021
Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
Checkpoint inhibitor (CPI) therapy has vastly improved long-term outcomes in metastatic malignant melanoma (MMM)
12 gen 2021
L’infermiere specialista in dermatologia
L'infermiere specialista in dermatologia ha esperienza e competenze per mettere in atto il Processo di Nursing
06 gen 2021
Vaccino anti covid e patologie dermatologiche
Pazienti affetti da patologie infiammatorie croniche (psoriasi, dermatite atopica, idrosadenite suppurativa etc.) e da patologie tumorali
05 gen 2021
Copertura assicurativa AON In convenzione SIDeMaST
SIDeMaST ha realizzato, in collaborazione con il broker Aon, una nuova copertura a tutela del patrimonio del professionista in caso di infortunio.
04 gen 2021
Convenzioni Assicurative Polizza Infortuni
Convenzioni Assicurative Polizza Infortuni
15 dic 2020
La scienza dermocosmetica scopre una nuova molecola per la psoriasi
Studi recenti hanno evidenziato che il Celastrol agisce sui mediatori dell’infiammazione tipica della psoriasi
14 dic 2020
Androgenetic alopecia in women and men
Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines
14 dic 2020
Immune checkpoint-mediated psoriasis
A multicentric European study of 115 patients from European Network for Cutaneous ADverse Event to Oncologic drugs (ENCADO) group
14 dic 2020
Dermatoscopy of combined blue nevi: A multicenter study of the International Dermoscopy Society
Combined blue nevi may mimic melanoma and are relatively often biopsied for diagnostic reasons.
11 dic 2020
GIDV - Anno 2020 - Volume 155 - Numero 5
Ottobre 2020 - Giornale Italiano di Dermatologia e Venereologia
10 dic 2020
COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies
Since the onset of the 2019-nCoV disease (COVID-19), many skin manifestations have been reported in COVID-19 patients
10 dic 2020
Skin barrier immunity and ageing
The skin is the outermost layer of the body with an extensive surface area of approximately 1·8 m2, and is the first line of defence against a multitude of external pathogens and environmental insults.
10 dic 2020
GIDV - Anno 2020 - Volume 155 - Numero 4
Agosto 2020 - Giornale Italiano di Dermatologia e Venereologia
03 dic 2020
Progetto Atopia Visita Virtuale
Il progetto “Atopia Visita Virtuale” nasce dall’esigenza di garantire ai pazienti una continuità assistenziale
02 dic 2020
The 2020 International Alliance for the Control of Scabies
Consensus Criteria for the Diagnosis of Scabies
02 dic 2020
Prurigo nodularis
Pathogenesis and management
02 dic 2020
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years
In this cohort study of 129 patients with vulvar melanosis and 5 to 20 years of follow-up, 67% of vulvar melanotic lesions appeared in premenopausal patients, and 65% of all patients had received some type of hormone therapy;
24 nov 2020
Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic
Risk Analysis from the PSO-BIO-COVID Observational Study
24 nov 2020
Autoimmunity in Segmental Vitiligo
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized.